Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
Sign Up to like & getrecommendations! Published in 2022 at "European Respiratory Review"
DOI: 10.1183/16000617.0121-2022
Abstract: Lower respiratory tract infections lead to significant morbidity and mortality. They are increasingly caused by multidrug-resistant pathogens, notably in individuals with cystic fibrosis, hospital-acquired pneumonia and lung transplantation. The use of bacteriophages (phages) to treat… read more here.
Keywords: phage therapy; clinical experiences; therapy pulmonary; therapy ... See more keywords
Pulmonary artery aneurysms: diagnosis & endovascular therapy.
Sign Up to like & getrecommendations! Published in 2018 at "Cardiovascular diagnosis and therapy"
DOI: 10.21037/cdt.2018.04.01
Abstract: Pulmonary artery aneurysms (PAAs) and pseudoaneurysms are rare entities in the spectrum of pulmonary arterial diseases. The etiology of these aneurysms is varied and patients present with nonspecific symptoms which make their diagnosis both difficult… read more here.
Keywords: pulmonary artery; therapy pulmonary; artery aneurysms; diagnosis ... See more keywords
Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases.
Sign Up to like & getrecommendations! Published in 2022 at "Current drug metabolism"
DOI: 10.2174/1389200223666220803103039
Abstract: The lung is exposed to various pollutants and is the primary site for the onset of various diseases, including infections, allergies, and cancers. One possible treatment approach for such pulmonary diseases involves direct administration of… read more here.
Keywords: therapy pulmonary; pulmonary diseases; based inhalation; nanoparticle based ... See more keywords
Fluid Therapy in Pulmonary Disease: How Careful Do We Need to Be?
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Veterinary Science"
DOI: 10.3389/fvets.2021.624833
Abstract: Intravenous fluid therapy is a vital and life-saving therapeutic in veterinary medicine. In the absence of heart or lung disease, trauma or sepsis there is limited evidence that fluid therapy will have a detrimental effect… read more here.
Keywords: fluid; disease; therapy pulmonary; fluid therapy ... See more keywords
The Therapy of Pulmonary Fibrosis in Paracoccidioidomycosis: What Are the New Experimental Approaches?
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Fungi"
DOI: 10.3390/jof6040217
Abstract: Pulmonary fibrosis (PF) is considered the most important sequela developed in patients suffering from the chronic form of paracoccidioidomycosis (PCM), which leads to the loss of respiratory function in 50% of cases; this residual pulmonary… read more here.
Keywords: fibrosis; therapy pulmonary; paracoccidioidomycosis new; fibrosis paracoccidioidomycosis ... See more keywords
Should We Change the Target of Therapy in Pulmonary Hypertension?
Sign Up to like & getrecommendations! Published in 2023 at "Life"
DOI: 10.3390/life13051202
Abstract: Despite the evolution of drug therapy in pulmonary arterial hypertension and the more aggressive treatment approach according to the guidelines, patients continue to have unacceptable mortality rates. Furthermore, specific drug therapy alone in chronic thromboembolic… read more here.
Keywords: target therapy; pulmonary hypertension; therapy pulmonary; hypertension ... See more keywords